Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Pulmonary Research of Abingdon, LLC
Country
Ownership
Private
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Examination of Pirfenidone (Esbriet®) Therapy in Coal Workers' Pneumoconiosis With Pulmonary Fibrosis
Phase 2
Completed
Conditions
Coal Workers' Pneumoconiosis (Complicated)
Interventions
Drug: Pirfenidone
Subscribe
First Posted Date
2020-07-08
Last Posted Date
2024-07-16
Lead Sponsor
Pulmonary Research of Abingdon, LLC
Target Recruit Count
50
Registration Number
NCT04461587
Locations
🇺🇸
Pulmonary Research of Abingdon, LLC, Abingdon, Virginia, United States
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy